Innovative Oncology Network Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 6.60 M
as on 28-06-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -82.90%
(FY 2020)
- Profit 48.36%
(FY 2020)
- Ebitda 43.65%
(FY 2020)
- Net Worth -87.20%
(FY 2020)
- Total Assets -87.47%
(FY 2020)
About Innovative Oncology Network
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 6.60 M, as per Ministry of Corporate Affairs (MCA) records.
Karan Singh and Sagar More serve as directors at the Company.
- CIN/LLPIN
U85300MH2018PTC304347
- Company No.
304347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Innovative Oncology Network?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar More  | Director | 18-Jan-2018 | Current |
| Karan Singh | Director | 15-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Innovative Oncology Network.
Innovative Oncology Network Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 82.9% decrease. The company also saw a substantial improvement in profitability, with a 48.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 87.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovative Oncology Network?
In 2018, Innovative Oncology Network had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Integrated Technology Solutions Private LimitedActive 23 years 6 months
Sagar More is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innovative Oncology Network?
Unlock and access historical data on people associated with Innovative Oncology Network, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovative Oncology Network, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovative Oncology Network's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
